Used primarily in research settings, this compound serves as a modified form of octreotide to enhance stability and bioavailability. It is investigated for its potential in targeted drug delivery, particularly in therapies involving hormone-secreting tumors. Due to the acetyl group protecting the active site, it allows for controlled release and prolonged activity in vivo. Its application extends to diagnostic imaging and treatment monitoring in neuroendocrine tumors when labeled with radioactive isotopes. Also explored in peptide-based prodrug development to improve metabolic resistance and tissue specificity.